Brief: Matinas Biopharma Reports Q2 Loss Per Share $0.40

Matinas BioPharma Holdings

10/08/2018 13:22

Aug 10 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA REPORTS SECOND QUARTER 2018 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.40
    * COMPANY ENDED QUARTER WITH CASH AND CASH EQUIVALENTS OF
APPROXIMATELY $8.9 MILLION

Source text for Eikon:  ID:nGNX32fFdk 
Further company coverage:  MTNB.A 

 (Reuters.Briefs@thomsonreuters.com)